Get the Stockscreener App
142.26
0.81%
1.15
After Hours:
142.50
0.24
+0.17%
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $142.26, with a volume of 2.26M.
It is up +0.81% in the last 24 hours and down -4.01% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$141.11
Open:
$141.26
24h Volume:
2.26M
Relative Volume:
0.75
Market Cap:
$63.05B
Revenue:
$9.39B
Net Income/Loss:
$2.62B
P/E Ratio:
24.48
EPS:
5.8121
Net Cash Flow:
$2.22B
1W Performance:
-2.13%
1M Performance:
-4.01%
6M Performance:
-4.80%
1Y Performance:
-25.16%
1-Day Range:
$140.65
$143.36
1-Week Range:
$140.65
$146.20
52-Week Range:
$139.34
$196.55
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain - Yahoo Finance
Zoetis Could Face Pressure if Recessionary Conditions Cause Pullback in Pet Health Spending - Morningstar
Leerink Partners Adjusts Zoetis' Price Target to $152 From $153, Keeps Market Perform Rating - MarketScreener
News impact scoring models applied to Zoetis Inc.Trade Risk Report & Safe Entry Trade Signal Reports - newser.com
Montrusco Bolton Investments Inc. Sells 102,497 Shares of Zoetis Inc. $ZTS - MarketBeat
Apollon Wealth Management LLC Acquires 6,057 Shares of Zoetis Inc. $ZTS - MarketBeat
Index Fund Advisors Inc. Invests $621,000 in Zoetis Inc. $ZTS - MarketBeat
Vanguard Personalized Indexing Management LLC Grows Holdings in Zoetis Inc. $ZTS - MarketBeat
Sector ETF performance correlation with Zoetis Inc.July 2025 Recap & Fast Entry Momentum Alerts - newser.com
What valuation ratios show for Zoetis Inc. (ZOE) stockQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
What analysts say about Zoetis Inc stockStock Buyback Announcements & High Profit Trading Signals - earlytimes.in
Fulcrum Capital LLC Buys 3,847 Shares of Zoetis Inc. $ZTS - MarketBeat
OFI Invest Asset Management Purchases 67,984 Shares of Zoetis Inc. $ZTS - MarketBeat
Stonehage Fleming Financial Services Holdings Ltd Has $98.04 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Callan Family Office LLC Has $2.45 Million Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. $ZTS Shares Sold by US Bancorp DE - MarketBeat
Zoetis Inc. (NYSE:ZTS) Announces Quarterly Dividend of $0.50 - MarketBeat
Galvin Gaustad & Stein LLC Raises Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Eastern Bank Has $3.77 Million Stock Position in Zoetis Inc. $ZTS - MarketBeat
Davis Rea LTD. Purchases 20,268 Shares of Zoetis Inc. $ZTS - MarketBeat
Blue Zone Wealth Advisors LLC Raises Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis’ dog osteoarthritis pain treatment receives positive EU opinion By Investing.com - Investing.com Nigeria
Zoetis (ZTS): EMA Supports New Canine Osteoarthritis Treatment - GuruFocus
Zoetis gains EMA panel endorsement for Lenivia for osteoarthritis pain in dogs - Seeking Alpha
Zoetis, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Zoetis (ZTS) Awaits EU Approval for Lenivia, an Osteoarthritis T - GuruFocus
Zoetis’ dog osteoarthritis pain treatment receives positive EU opinion - Investing.com
(izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs - Business Wire
Zoetis (ZTS): Assessing Valuation Following Dividend Announcement and FDA Nod for Dectomax-CA1 Injectable - Yahoo Finance
Regression analysis insights on Zoetis Inc. performanceJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
Using Python tools to backtest Zoetis Inc. strategies2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Market reaction to Zoetis Inc.’s recent newsJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
Blair William & Co. IL Sells 260,409 Shares of Zoetis Inc. $ZTS - MarketBeat
Live market analysis of Zoetis Inc.2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Is Zoetis Inc. Class stock undervalued at current price2025 Top Decliners & AI Optimized Trading Strategy Guides - newser.com
Zoetis Inc. $ZTS Stock Position Decreased by NBT Bank N A NY - MarketBeat
Is Zoetis Inc. (ZOE) stock a buy during volatile marketsPortfolio Performance Report & Consistent Return Investment Signals - newser.com
How Zoetis Inc. (ZOE) stock trades under stagflationQuarterly Market Summary & Real-Time Volume Analysis Alerts - newser.com
Zoetis Inc. (ZTS) Announces Fourth Quarter Dividend - GuruFocus
Zoetis (NYSE:ZTS) Signals Robust Health with Q4 2025 Dividend Declaration, Bolstering Investor Confidence in Animal Health Sector - FinancialContent
Gothenburg FFA Chapter Receives Donation From Zoetis - Gothenburg Leader
Zoetis (NYSE:ZTS) Declares $0.50 Q4 2025 Dividend, Signaling Robust Animal Health Market - FinancialContent
Zoetis (ZTS) Maintains Quarterly Dividend, Sets Payment Date - GuruFocus
Zoetis declares $0.50 per share dividend for fourth quarter 2025 By Investing.com - Investing.com South Africa
Zoetis Inc. Declares Fourth Quarter 2025 Dividend, Payable on December 2, 2025 - MarketScreener
Zoetis Declares Q4 2025 Dividend of $0.50 - TipRanks
Zoetis declares $0.50 per share dividend for fourth quarter 2025 - Investing.com
Zoetis Declares Fourth Quarter 2025 Dividend - The Joplin Globe
Zoetis Inc. $ZTS Position Cut by Vontobel Holding Ltd. - MarketBeat
Understanding Zoetis Inc.’s price movementWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Is Zoetis Inc. stock a good choice for value investorsJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):